Learning Center

Your central location for online learning and education surrounding all aspects of tissue donation, tissue banking, research and transplantation.

Regulatory Pathways and Considerations for Medical Products Derived from Birth Tissue (Group)

In this session, we will review of how birth tissue transplants are regulated by FDA and special considerations associated with this unique tissue type.

John Mayhall, MS

Regulatory Affairs Specialist II

StimLabs, LLC

John is a Regulatory Affairs Specialist II at StimLabs, LLC. John has a bachelor’s degree in microbiology from Auburn University and a Master’s Degree in Regulatory Affairs from the University of Georgia. John is an expert in the regulation of both HCT/Ps and medical devices, including Quality System regulations, submissions, registration and licensure.

Key:

Complete
Failed
Available
Locked
Regulatory Pathways and Considerations for Medical Products Derived from Birth Tissue
Select the "View On-Demand Recording" button to begin.  |  60 minutes
Select the "View On-Demand Recording" button to begin.  |  60 minutes
You must register to access.
Presentation Survey
6 Questions
6 Questions
You must register to access.
Certificate of Attendance
No credits available  |  Certificate available
No credits available  |  Certificate available
You must register to access.
Presentation Slides
Open to download resource.
Open to download resource.
You must register to access.